Berry Melanie E, Chapple Iva T, Ginsberg Jay P, Gleichauf Kurt J, Meyer Jeff A, Nagpal Madan L
Wm. Jennings Bryan Dorn VA Medical Center, Columbia, South Carolina, United States.
Glob Adv Health Med. 2014 Mar;3(2):28-33. doi: 10.7453/gahmj.2013.075.
Chronic pain is an emotionally and physically debilitating form of pain that activates the body's stress response and over time can result in lowered heart rate variability (HRV) power, which is associated with reduced resiliency and lower self-regulatory capacity. This pilot project was intended to determine the effectiveness of HRV coherence biofeedback (HRVCB) as a pain and stress management intervention for veterans with chronic pain and to estimate the effect sizes. It was hypothesized that HRVCB will increase parasympathetic activity resulting in higher HRV coherence measured as power and decrease self-reported pain symptoms in chronic pain patients.
Fourteen veterans receiving treatment for chronic pain were enrolled in the pre-post intervention study. They were randomly assigned, with 8 subjects enrolled in the treatment group and 6 in the control group. The treatment group received biofeedback intervention plus standard care, and the other group received standard care only. The treatment group received four HRVCB training sessions as the intervention.
Pre-post measurements of HRV amplitude, HRV power spectrum variables, cardiac coherence, and self-ratings of perceived pain, stress, negative emotions, and physical activity limitation were made for both treatment and control groups.
The mean pain severity for all subjects at baseline, using the self-scored Brief Pain Inventory (BPI), was 26.71 (SD=4.46; range=21-35) indicating a moderate to severe perceived pain level across the study subjects. There was no significant difference between the treatment and control groups at baseline on any of the measures. Post-HRVCB, the treatment group was significantly higher on coherence (P=.01) and lower (P=.02) on pain ratings than the control group. The treatment group showed marked and statistically significant (1-tailed) increases over the baseline in coherence ratio (191%, P=.04) and marked, significant (1-tailed) reduction in pain ratings (36%, P<.001), stress perception (16%, P=.02), negative emotions (49%, P<.001), and physical activity limitation (42%, P<.001). Significant between-group effects on all measures were found when pre-training values were used as covariates.
HRVCB intervention was effective in increasing HRV coherence measured as power in the upper range of the LF band and reduced perceived pain, stress, negative emotions, and physical activity limitation in veterans suffering from chronic pain. HRVCB shows promise as an effective non-pharmacological intervention to support standard treatments for chronic pain.
慢性疼痛是一种在情感和身体上使人衰弱的疼痛形式,它会激活身体的应激反应,随着时间的推移,可能会导致心率变异性(HRV)功率降低,这与恢复力下降和自我调节能力降低有关。这个试点项目旨在确定HRV相干生物反馈(HRVCB)作为慢性疼痛退伍军人疼痛和压力管理干预措施的有效性,并估计效应大小。研究假设是,HRVCB将增加副交感神经活动,从而导致以功率衡量的更高的HRV相干性,并减少慢性疼痛患者自我报告的疼痛症状。
14名接受慢性疼痛治疗的退伍军人参加了干预前后的研究。他们被随机分配,8名受试者进入治疗组,6名进入对照组。治疗组接受生物反馈干预加标准护理,另一组仅接受标准护理。治疗组接受四次HRVCB训练课程作为干预。
对治疗组和对照组进行HRV振幅、HRV功率谱变量、心脏相干性以及疼痛、压力、负面情绪和身体活动限制的自我评分的干预前后测量。
使用自我评分的简明疼痛量表(BPI),所有受试者在基线时的平均疼痛严重程度为26.71(标准差=4.46;范围=21 - 35),表明整个研究对象的疼痛感知水平为中度至重度。在任何测量指标上,治疗组和对照组在基线时均无显著差异。HRVCB干预后,治疗组的相干性显著高于对照组(P = 0.01),疼痛评分显著低于对照组(P = 0.02)。治疗组的相干比相对于基线有显著且具有统计学意义(单尾)的增加(191%,P = 0.04),疼痛评分、压力感知(16%,P = 0.02)、负面情绪(49%,P < 0.001)和身体活动限制(42%,P < 0.001)有显著且具有统计学意义(单尾)的降低。当将训练前的值用作协变量时,发现所有测量指标在组间均有显著影响。
HRVCB干预有效地增加了以低频带较高范围的功率衡量的HRV相干性,并降低了慢性疼痛退伍军人的疼痛感知、压力、负面情绪和身体活动限制。HRVCB作为一种有效的非药物干预措施,有望支持慢性疼痛的标准治疗。